Glyoxalase I inhibitors in cancer chemotherapy

Biochemical Society Transactions

Volumn 31, Issue 6, 2003, Pages 1378-1382

  Creighton, D J ^a   Zheng, Z B ^a   Holewinski, R ^a   Hamilton, D S ^a   Eiseman, J L ^b  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Anticancer agent; Glyoxalase I; Inhibitor; Prodrug

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTATHIONE DERIVATIVE; LACTOYLGLUTATHIONE LYASE; LACTOYLGLUTATHIONE LYASE INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CONFERENCE PAPER; CRYSTAL STRUCTURE; DRUG CLEARANCE; DRUG DESIGN; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; MAXIMUM TOLERATED DOSE; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0347228987     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/bst0311378     Document Type: Conference Paper

References (28)

1. Vander Jagt, D.L. (1989) in Coenzymes and Cofactors: Glutathione, vol. 3, part A (Dolphin, D., Poulson, R. and Avramovic, O., eds.), pp. 597-641, John Wiley and Sons, New York
2. Creighton, D.J. and Pourmotabbed, T. (1988) in Molecular Structure and Energetics: Principles of Enzyme Activity, vol. 9 (Liebman, J.L. and Greenberg, A., eds.), pp. 353-386, VCH Publishers, New York
3. Thornalley, P.J. (1998) Chem.-Biol. Interact. 111-112, 137-151
4. Richard, J.P. (1991) Biochemistry 30, 4581-4585
5. White, J.S. and Rees, K.R. (1982) Chem.-Biol. Interact. 38, 339-347
6. Papoulis, A., Al-Abed, Y. and Bucala, R. (1995) Biochemistry 34, 648-655
7. Shih, M.J., Edinger, J.W. and Creighton, D.J. (1997) Eur. J. Biochem. 244, 852-857
8. Creighton, D.J., Migliorini, M. and Pourmotabbed, T. (1988) Biochemistry 27, 7376-7384
9. Vince, R. and Daluge, S. (1971) J. Med. Chem. 14, 35-37
10. Reiffen, K.A. and Schneeder, F.A. (1984) J. Cancer Res. Clin. Oncol. 107, 206-210
11. Ayoub, F.M., Allen, R.E. and Thornalley, P.J. (1993) Leukocyte Res. 17, 397-401
12. Amicarelli, F., Bucciarelli, T., Poma, A., Aimola, P., Di Ilio, C., Ragnelli, A.M. and Miranda, M. (1998) Carcinogenesis 19, 519-523
13. Okada, A., Kawasaki, Y., Hasuike, Y., Takahashi, M., Teshima, T., Fujii, J. and Taniguchi, N. (1996) Biochem. Biophys. Res. Commun. 225, 219-224
14. Murthy, N.S.R.K., Bakeris, T., Kavarana, M.J., Hamilton, D.S., Lan, Y. and Creighton, D.J. (1994) J. Med. Chem. 37, 2161-2166
15. Vince, R., Daluge, S. and Wadd, W.B. (1971) J. Med. Chem. 14, 402-404
16. Vince, R., Brownell, J. and Akella, L.B. (1999) Bioorg. Med. Chem. Lett. 9, 853-856
17. Hamilton, D.S. and Creighton, D.J. (1992) J. Biol. Chem. 267, 24933-24936
18. Kalsi, A., Kavarana, M.J., Lu, T., Whalen, D.L. Hamilton, D.S. and Creighton, D.J. (2000) J. Med. Chem. 43, 3981-3986
19. Cameron, A.D., Ridderström, M., Olin, B., Kavarana, M.J., Creighton, D.J. and Mannervik, B. (1999) Biochemistry 38, 13480-13490
20. Lo, T.W.C. and Thornalley, P.J. (1992) Biochem. Pharmacol. 44, 2357-2363
21. Kavarana, M.J., Kovaleva, E.G., Creighton, D.J. and Eiseman, J.L. (1999) J. Med. Chem. 42, 221-228
22. Hamilton, D.S., Kavarana, M.J., Sharkey, E.M., Creighton, D.J. and Eiseman, J.L. (1999) J. Med. Chem. 42, 1823-1827
23. Takakura, Y. and Hashida, M. (1996) Pharm. Rev. 13, 820-831
24. Seymour, L.W., Ulrich, K., Wedge, S.R., Hume, I.C., Strohalm, J. and Duncan, R. (1991) Br. J. Cancer 63, 859-866
25. Thornalley, P.J., Ladan, M.J., Ridgeway, S.J.S. and Kang, Y. (1996) J. Med. Chem. 39, 3409-3411
26. Thornalley, P.J., Edwards, L.G., Kang, Y.W., Wyatt, C., Davies, N., Ladan, M.J. and Double, J. (1996) Biochem. Pharmacol. 51, 1365-1372
27. Creighton, D.J., Hamilton, D.S., Kavarana, M.J., Sharkey, E.M. and Eiseman, J.L. (2000) Drugs Future 25, 385-392
28. Sharkey, E.M., O'Neill, H.B., Kovaleva, E.G., Kavarana, M.J., Wang, H., Creighton, D.J., Sentz, D.L. and Eiseman, J.L. (2000) Cancer Chemother. Pharmacol. 46, 156-166